Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Vaccine Immunol ; 23(6): 442-50, 2016 06.
Article in English | MEDLINE | ID: mdl-27030589

ABSTRACT

Staphylococcus aureus alpha-hemolysin (Hla) assembles into heptameric pores on the host cell membrane, causing lysis, apoptosis, and junction disruption. Herein, we present the design of a newly engineered S. aureus alpha-toxin, HlaPSGS, which lacks the predicted membrane-spanning stem domain. This protein is able to form heptamers in aqueous solution in the absence of lipophilic substrata, and its structure, obtained by transmission electron microscopy and single-particle reconstruction analysis, resembles the cap of the wild-type cytolytic Hla pore. HlaPSGS was found to be impaired in binding to host cells and to its receptor ADAM10 and to lack hemolytic and cytotoxic activity. Immunological studies using human sera as well as sera from mice convalescent from S. aureus infection suggested that the heptameric conformation of HlaPSGS mimics epitopes exposed by the cytolytic Hla pore during infection. Finally, immunization with this newly engineered Hla generated high protective immunity against staphylococcal infection in mice. Overall, this study provides unprecedented data on the natural immune response against Hla and suggests that the heptameric HlaPSGS is a highly valuable vaccine candidate against S. aureus.


Subject(s)
Bacterial Toxins/chemistry , Bacterial Toxins/immunology , Hemolysin Proteins/chemistry , Hemolysin Proteins/immunology , Molecular Mimicry , Staphylococcal Infections/prevention & control , Staphylococcus aureus , ADAM10 Protein/metabolism , Animals , Bacterial Toxins/administration & dosage , Bacterial Toxins/genetics , Cell Line , Cytotoxins , Epitopes/immunology , Escherichia coli/genetics , Hemolysin Proteins/administration & dosage , Hemolysin Proteins/genetics , Humans , Membrane Proteins/metabolism , Mice , Microscopy, Electron, Transmission , Models, Molecular , Protein Engineering , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Staphylococcal Vaccines/immunology , Staphylococcus aureus/chemistry , Staphylococcus aureus/metabolism , Vaccination
2.
Mol Cell Proteomics ; 14(2): 418-29, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25368410

ABSTRACT

New generation vaccines are in demand to include only the key antigens sufficient to confer protective immunity among the plethora of pathogen molecules. In the last decade, large-scale genomics-based technologies have emerged. Among them, the Reverse Vaccinology approach was successfully applied to the development of an innovative vaccine against Neisseria meningitidis serogroup B, now available on the market with the commercial name BEXSERO® (Novartis Vaccines). The limiting step of such approaches is the number of antigens to be tested in in vivo models. Several laboratories have been trying to refine the original approach in order to get to the identification of the relevant antigens straight from the genome. Here we report a new bioinformatics tool that moves a first step in this direction. The tool has been developed by identifying structural/functional features recurring in known bacterial protective antigens, the so called "Protectome space," and using such "protective signatures" for protective antigen discovery. In particular, we applied this new approach to Staphylococcus aureus and Group B Streptococcus and we show that not only already known protective antigens were re-discovered, but also two new protective antigens were identified.


Subject(s)
Bacterial Vaccines/immunology , Computational Biology/methods , Proteome/immunology , 5'-Nucleotidase/metabolism , Animals , Bacterial Proteins/immunology , Cell Line , Disease Models, Animal , Female , Mice , Neisseria meningitidis, Serogroup B/immunology , Protein Sorting Signals , Reproducibility of Results , Staphylococcus aureus/immunology , Streptococcus agalactiae/immunology
3.
PLoS One ; 8(4): e61294, 2013.
Article in English | MEDLINE | ID: mdl-23585887

ABSTRACT

Although the contribution of carbohydrate catabolism to bacterial colonization and infection is well recognized, the transcriptional changes during these processes are still unknown. In this study, we have performed comparative global gene expression analysis of GBS in sugar-free versus high glucose milieu. The analysis revealed a differential expression of genes involved in metabolism, transport and host-pathogen interaction. Many of them appeared to be among the genes previously reported to be controlled by the CovRS two-component system. Indeed, the transcription profile of a ΔcovRS strain grown in high-glucose conditions was profoundly affected. In particular, of the total genes described to be regulated by glucose, ∼27% were under CovRS control with a functional role in protein synthesis, transport, energy metabolism and regulation. Among the CovRS dependent genes, we found bibA, a recently characterized adhesin involved in bacterial serum resistance and here reported to be down-regulated by glucose. ChIP analysis revealed that in the presence of glucose, CovR binds bibA promoter in vivo, suggesting that CovR may act as a negative regulator or a repressor. We also demonstrated that, as for other target promoters, chemical phosphorylation of CovR in aspartic acid increases its affinity for the bibA promoter region. The data reported in this study contribute to the understanding of the molecular mechanisms modulating the adaptation of GBS to glucose.


Subject(s)
Adaptation, Biological/genetics , Adhesins, Bacterial/genetics , Gene Expression Regulation, Bacterial , Glucose/metabolism , Streptococcus agalactiae/genetics , Adhesins, Bacterial/metabolism , Escherichia coli/genetics , Gene Expression Profiling , Genes, Regulator , Phosphorylation , Promoter Regions, Genetic , Protein Binding , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Streptococcus agalactiae/metabolism , Transcription, Genetic
4.
J Bacteriol ; 192(7): 1882-9, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20097853

ABSTRACT

Identification of interacting proteins in stable complexes is essential to understand the mechanisms that regulate cellular processes at the molecular level. Transcription initiation in prokaryotes requires coordinated protein-protein and protein-DNA interactions that often involve one or more transcription factors in addition to RNA polymerase (RNAP) subunits. The RNAP alpha subunit (RNAPalpha) is a key regulatory element in gene transcription and functions through direct interaction with other proteins to control all stages of this process. A clear description of the RNAPalpha protein partners should greatly increase our understanding of transcription modulation. A functional proteomics approach was employed to investigate protein components that specifically interact with RNAPalpha. A tagged form of Escherichia coli RNAPalpha was used as bait to determine the molecular partners of this subunit in a whole-cell extract. Among other interacting proteins, 50S ribosomal protein L2 (RPL2) was clearly identified by mass spectrometry. The direct interaction between RNAPalpha and RPL2 was confirmed both in vivo and in vitro by performing coimmunoprecipitation and bacterial two-hybrid experiments. The functional role of this interaction was also investigated in the presence of a ribosomal promoter by using a beta-galactosidase gene reporter assay. The results clearly demonstrated that RPL2 was able to increase beta-galactosidase expression only in the presence of a specific ribosomal promoter, whereas it was inactive when it was assayed with an unrelated promoter. Interestingly, other ribosomal proteins (L1, L3, L20, and L27) did not have any effect on rRNA expression. The findings reported here strongly suggest that in addition to its role in ribosome assembly the highly conserved RPL2 protein plays a specific and direct role in regulation of transcription.


Subject(s)
DNA-Directed RNA Polymerases/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/physiology , Gene Expression Regulation, Bacterial , Ribosomal Proteins/metabolism , Transcription, Genetic , Genes, Reporter , Genes, rRNA , Mass Spectrometry , Promoter Regions, Genetic , Protein Binding , Two-Hybrid System Techniques , beta-Galactosidase/biosynthesis , beta-Galactosidase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL